“…The prolonged hypoglycemic state from 4 h PI to 36 h PI after a single injection of tolbutamide, associated with a profound rise in plasma insulin concentrations at 0.5 h PI, is in agreement with in vitro and in vivo studies on layer and broiler chickens at different ages [9,[14][15][16][17][18][25][26][27][28] and with in vitro and in vivo studies on mice, rats, dogs, and hamsters [29][30][31][32][33]. Indeed, tolbutamide is a potent hypoglycemic agent in mammals and birds and stimulates insulin secretion from pancreatic b-cells, principally by inhibiting adenosine triphosphatesensitive K þ channels in the cell membrane, consequently, causing a membrane depolarization and an activation of voltage-gated Ca 2þ influx [34][35][36].…”